TTM Technologies, Inc. Completes Acquisition of Epiq Solutions, Enhancing TTM’s Strategic A&D Portfolio

TTM Technologies completed its $1.1 billion all-cash acquisition of Epiq Design Solutions, adding AI-enabled software-defined radios, RF products and radiation-tolerant space-computing capabilities for aerospace and defense applications. The deal is expected to be immediately accretive to adjusted EBITDA, moderately dilutive to non-GAAP diluted EPS in 2027, and accretive in 2028. TTM financed the transaction with $1.1 billion of incremental secured term loans ($300 million Term Loan A and $800 million Term Loan B) plus proceeds from previously issued 6.750% senior notes due 2034.

Analysis

The key equity question is not revenue synergies but whether TTM can convert a lower-multiple manufacturing profile into a higher-value mission-electronics platform without allowing incremental interest expense to absorb the EBITDA uplift. Immediate EBITDA accretion alongside 2027 EPS dilution implies financing cost, purchase accounting and/or amortization are material; investors should expect the stock’s first reaction to be constrained until pro forma leverage, cash interest and Epiq’s standalone margin are disclosed. The acquisition’s strategic value rests on attaching proprietary content and recurring software/support potential to TTM’s existing interconnect footprint, which could lift mix and customer stickiness over 6-18 months.

A second-order positive is improved positioning in programs where SWaP constraints make PCB, RF and compute design interdependent; that can expand TTM’s share of system content rather than merely raise PCB volumes. The offset is customer concentration and procurement power: major defense primes including LHX, RTX and NOC may welcome a more integrated supplier but will resist margin expansion if Epiq’s technology is not genuinely differentiated or if open-architecture designs reduce switching costs. MRCY is the closest public read-through on rugged processing and defense-electronics execution, though its operating issues make it an imperfect comp.

Consensus may over-credit the AI/defense label before verifying backlog quality and conversion timing. This is a debt-funded acquisition in a business with long qualification cycles, so the near-term catalyst is disclosure-driven rather than contract-driven: the next 10-Q and earnings call need to establish pro forma net leverage, annualized cash interest, Epiq revenue/EBITDA contribution, backlog duration and expected integration costs. A material rise in leverage, weaker-than-expected free-cash-flow conversion, or movement of EPS accretion beyond 2028 would falsify the rerating thesis.

Key Decisions for Investors

• Maintain TTMI as a watch-to-buy rather than chase the closing headline; initiate a 1-3 month long only if management discloses pro forma net leverage below roughly 3.5x, credible deleveraging toward 3.0x within 18 months, and Epiq EBITDA margins above TTM’s legacy corporate margin. The upside is multiple expansion from mix improvement; the principal downside is debt-driven EPS pressure.
• At the next earnings release, buy TTMI on confirmation that Epiq backlog converts into 2027 revenue without incremental restructuring or integration charges; use a 6-18 month horizon and reassess if 2027 non-GAAP EPS dilution worsens versus current expectations.
• For a relative-value expression after disclosure, consider long TTMI / short MRCY in equal sector-beta weights if TTMI demonstrates positive defense-electronics margin mix while MRCY continues to show weak organic growth or margin recovery. Exit if MRCY’s order growth reaccelerates materially or TTMI’s pro forma leverage exceeds management’s deleveraging capacity.
• Set alerts for the 10-Q debt footnote and 2027 guidance: cash interest expense, debt maturities, covenant headroom, Epiq revenue concentration and any contingent consideration are the missing variables that determine whether EBITDA accretion translates into equity value.